Home/Pipeline/CUSTOM FLEX® ARTIFICIAL IRIS

CUSTOM FLEX® ARTIFICIAL IRIS

Iris defects (Aniridia)

ApprovedActive

Key Facts

Indication
Iris defects (Aniridia)
Phase
Approved
Status
Active
Company

About VEO Ophthalmics

VEO Ophthalmics is a private, commercial-stage medical device company specializing in ophthalmic surgical tools. The company achieved a significant regulatory milestone with the FDA's first Breakthrough Device designation and approval for its CUSTOM FLEX® Artificial Iris, addressing iris defects. With a second commercial product, PLEXITOME™, for corneal conditions, VEO operates in a high-value niche, leveraging direct surgeon feedback to drive innovation and commercial execution in the ophthalmology market.

View full company profile

Therapeutic Areas